DEA: Cambrex High Point Seeks Manufacturing Registration for Opioids
August 22, 2025
August 22, 2025
WASHINGTON, Aug. 22 (TNSFR) -- Cambrex High Point Inc., High Point, North Carolina, has put in a request with the U.S. Department of Justice Drug Enforcement Administration to be registered as a bulk manufacturer of oxymorphone and noroxymorphone. These are potent opioid substances.
The application, submitted on July 18, 2025, specifies that the company intends to produce the drugs in bulk. This production would serve two purposes: for use as internal intermediates within its own op . . .
The application, submitted on July 18, 2025, specifies that the company intends to produce the drugs in bulk. This production would serve two purposes: for use as internal intermediates within its own op . . .